• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转甲状腺素蛋白淀粉样心肌病患者的超声心动图表现

Echocardiographic findings of patients with transthyretin amyloid cardiomyopathy.

作者信息

Usuku Hiroki, Oike Fumi, Kuyama Naoto, Hirakawa Kyoko, Takashio Seiji, Izumiya Yasuhiro, Tsujita Kenichi

机构信息

Department of Laboratory Medicine, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

出版信息

J Echocardiogr. 2025 Mar;23(1):1-9. doi: 10.1007/s12574-024-00672-w. Epub 2024 Dec 27.

DOI:10.1007/s12574-024-00672-w
PMID:39729212
Abstract

Transthyretin amyloid cardiomyopathy (ATTR-CM) is becoming increasingly recognized with the aging population, advancements in understanding of disease pathobiology and the potential benefits of emerging therapies. Bone scintigraphy, including Tc-labeled pyrophosphate scintigraphy, is currently considered the first-line modality for identifying ATTR-CM. Therefore, it is important to increase the preset probability using inexpensive and simple tests including echocardiography. Although there were a lot of typical echocardiographic findings of amyloid cardiomyopathy, unexplained left ventricular (LV) wall thickness, LV apical sparing, and a discrepancy between LV wall thickness and QRS voltage were selected as red flags/clues for ATTR-CM in various current diagnostic algorithms. Although echocardiography is useful for ATTR-CM screening, there are several limitations. Therefore, it is important to perform echocardiography and combine it with physical examination, laboratory findings, and other imaging data.

摘要

随着人口老龄化、对疾病病理生物学认识的进步以及新兴疗法的潜在益处,转甲状腺素蛋白淀粉样变心肌病(ATTR-CM)越来越受到关注。骨闪烁显像,包括锝标记焦磷酸盐闪烁显像,目前被认为是识别ATTR-CM的一线检查方法。因此,使用包括超声心动图在内的廉价且简单的检查来提高预设概率很重要。虽然淀粉样变心肌病有许多典型的超声心动图表现,但在目前各种诊断算法中,无法解释的左心室(LV)壁厚度、LV心尖 sparing以及LV壁厚度与QRS电压之间的差异被选为ATTR-CM的警示信号/线索。虽然超声心动图对ATTR-CM筛查有用,但也有一些局限性。因此,进行超声心动图检查并将其与体格检查、实验室检查结果及其他影像学数据相结合很重要。

相似文献

1
Echocardiographic findings of patients with transthyretin amyloid cardiomyopathy.转甲状腺素蛋白淀粉样心肌病患者的超声心动图表现
J Echocardiogr. 2025 Mar;23(1):1-9. doi: 10.1007/s12574-024-00672-w. Epub 2024 Dec 27.
2
Technetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy.锝焦磷酸盐闪烁扫描术:转甲状腺素淀粉样变心肌病早期诊断的实用指南。
ESC Heart Fail. 2022 Feb;9(1):251-262. doi: 10.1002/ehf2.13693. Epub 2021 Nov 29.
3
Transthyretin amyloid cardiomyopathy in patients with unexplained increased left ventricular wall thickness.原因不明的左心室壁增厚患者的转甲状腺素蛋白淀粉样心肌病。
Int J Cardiovasc Imaging. 2024 Aug;40(8):1693-1703. doi: 10.1007/s10554-024-03158-z. Epub 2024 Jun 10.
4
Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis.优化超声心动图参数以提高 Tc-99m-骨亲合示踪剂心肌闪烁显像诊断转甲状腺素蛋白心脏淀粉样变性的诊断率。
Circ Cardiovasc Imaging. 2022 Nov;15(11):e014645. doi: 10.1161/CIRCIMAGING.122.014645. Epub 2022 Nov 15.
5
Right Ventricular Strain Improves the Echocardiographic Diagnosis and Risk Stratification of Transthyretin Cardiac Amyloidosis Among Other Phenotypes of Left Ventricular Hypertrophy.右室应变提高了超声心动图对转甲状腺素蛋白心脏淀粉样变的诊断和危险分层,而转甲状腺素蛋白心脏淀粉样变属于左心室肥厚的其他表型。
J Am Soc Echocardiogr. 2024 Oct;37(10):947-959. doi: 10.1016/j.echo.2024.06.006. Epub 2024 Jun 26.
6
Diversity of heart failure phenotypes in transthyretin amyloid cardiomyopathy. More than just heart failure with preserved ejection fraction.转甲状腺素蛋白淀粉样变心肌病中心力衰竭表型的多样性。不只是射血分数保留的心力衰竭。
Ann Med. 2024 Dec;56(1):2418965. doi: 10.1080/07853890.2024.2418965. Epub 2024 Oct 26.
7
Routine 4D Cardiac CT to Identify Concomitant Transthyretin Amyloid Cardiomyopathy in Older Adults with Severe Aortic Stenosis.常规 4D 心脏 CT 识别老年严重主动脉瓣狭窄患者合并转甲状腺素蛋白淀粉样心肌病。
Radiology. 2023 Dec;309(3):e230425. doi: 10.1148/radiol.230425.
8
The diagnostic yield of non-invasive testing features in cardiac amyloidosis.心脏淀粉样变性中非侵入性检测特征的诊断价值
Nucl Med Rev Cent East Eur. 2025;28(0):1-8. doi: 10.5603/nmr.103627.
9
Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality.转甲状腺素蛋白心脏淀粉样变中焦磷酸盐摄取的区域差异及其对死亡率的影响。
JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 1):234-242. doi: 10.1016/j.jcmg.2017.06.020. Epub 2017 Oct 5.
10
First report of the clinical characteristics and outcomes of cardiac amyloidosis in Saudi Arabia.沙特阿拉伯心脏淀粉样变性临床特征与转归的首次报告。
ESC Heart Fail. 2024 Dec;11(6):4348-4359. doi: 10.1002/ehf2.15045. Epub 2024 Sep 1.

本文引用的文献

1
Cardiac Biomarker Change at 1 Year After Tafamidis Treatment and Clinical Outcomes in Patients With Transthyretin Amyloid Cardiomyopathy.替米沙坦治疗 1 年后心脏生物标志物的变化与转甲状腺素蛋白淀粉样心肌病患者的临床结局。
J Am Heart Assoc. 2024 May 21;13(10):e034518. doi: 10.1161/JAHA.124.034518. Epub 2024 May 18.
2
Novel echocardiographic pixel intensity quantification method for differentiating transthyretin cardiac amyloidosis from light chain cardiac amyloidosis and other phenocopies.用于区分转甲状腺素蛋白心脏淀粉样变性与轻链心脏淀粉样变性及其他表型模拟的新型超声心动图像素强度量化方法。
Eur Heart J Cardiovasc Imaging. 2024 Oct 30;25(11):1601-1611. doi: 10.1093/ehjci/jeae095.
3
Diagnostic significance of paradoxical left ventricular hypertrophy in detecting cardiac amyloidosis.
矛盾性左心室肥厚在检测心脏淀粉样变性中的诊断意义。
Int J Cardiol Heart Vasc. 2023 Oct 13;49:101279. doi: 10.1016/j.ijcha.2023.101279. eCollection 2023 Dec.
4
The diagnostic value of global longitudinal strain combined with cardiac biomarkers on early detection of anthracycline-related cardiac dysfunction.全球纵向应变与心脏标志物联合检测对蒽环类药物相关心功能障碍的早期诊断价值。
J Echocardiogr. 2023 Dec;21(4):165-172. doi: 10.1007/s12574-023-00618-8. Epub 2023 Jul 15.
5
How Often Does Apical Sparing of Longitudinal Strain Indicate the Presence of Cardiac Amyloidosis?纵向应变节段性保留频率能在多大程度上提示心脏淀粉样变性?
Am J Cardiol. 2023 Sep 1;202:12-16. doi: 10.1016/j.amjcard.2023.06.022. Epub 2023 Jul 4.
6
Prevalence of Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release With Amyloid Deposition.腕管松解术中伴有淀粉样蛋白沉积患者的心脏淀粉样变性患病率。
Circ J. 2023 Jul 25;87(8):1047-1055. doi: 10.1253/circj.CJ-23-0223. Epub 2023 Jun 13.
7
Relative apical sparing in cardiac amyloidosis is not always explained by an amyloid gradient.心脏淀粉样变的相对心尖保留并不总是由淀粉样变梯度解释。
Eur Heart J Cardiovasc Imaging. 2023 Aug 23;24(9):1258-1268. doi: 10.1093/ehjci/jead107.
8
Impact of Tafamidis on Echocardiographic Cardiac Function of Patients With Transthyretin Cardiac Amyloidosis.他法米地对转甲状腺素蛋白心脏淀粉样变性患者超声心动图心脏功能的影响。
Circ J. 2023 Mar 24;87(4):508-516. doi: 10.1253/circj.CJ-22-0683. Epub 2023 Mar 4.
9
2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee.2023年美国心脏病学会关于心脏淀粉样变性患者综合多学科护理的专家共识决策路径:美国心脏病学会解决方案集监督委员会报告
J Am Coll Cardiol. 2023 Mar 21;81(11):1076-1126. doi: 10.1016/j.jacc.2022.11.022. Epub 2023 Jan 23.
10
Time-dependent change of relative apical longitudinal strain index in patients with wild-type transthyretin amyloid cardiomyopathy.野生型转甲状腺素蛋白淀粉样心肌病患者相对心尖纵向应变指数的时间依赖性变化。
Int J Cardiol Heart Vasc. 2022 Nov 5;43:101146. doi: 10.1016/j.ijcha.2022.101146. eCollection 2022 Dec.